Abdul Mannan: Here’s when Your POC INR Machine Misleads You
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, shared a post on LinkedIn:
“Your POC INR device will give you a number on a DOAC patient.
Confidently. Immediately. Completely useless.
This is one of the most common ward-level anticoagulation errors I see.
Here’s when your POC INR machine misleads you:
- Triple-positive APS (LA + aCL + anti-β2GPI): may dramatically underestimate true anticoagulation intensity
- DOACs: the device still displays a result. That result means nothing.
- Haematocrit below 25% or above 55%: mechanical detection methods are especially affected
- High paraprotein: viscosity throws off clot-based chemistries
Why does this happen?
Most modern POC devices (CoaguChek XS family) don’t measure fibrin formation. They measure thrombin generation via a synthetic substrate.
That’s the source of the interference.
Successive BSH and ISTH guidance has been explicit: Triple-positive APS patients must not be monitored with POC INR devices.
I’ve just published a free interactive reference covering all 5 major UK POC INR devices, the electrochemical principle (with an animated amperometric cell diagram), a full pre/post-analytical procedure, limitations taxonomy, and the safety non-negotiables.
Free to use, no login.
What’s the trickiest POC INR case you’ve had to escalate?”
Other posts from Abdul Mannan on Hemostasis Today.
-
May 10, 2026, 15:28Joe Liechty: How It is Essentially Never too Late to Intervene on Chronic Venous Obstructions
-
May 10, 2026, 15:19Islam Arid: Why We Say ‘Time is Brain’ when It’s Coming to Stroke Management?
-
May 10, 2026, 15:14Could You Recognize Thrombotic Thrombocytopenic Purpura (TTP) in Time? – ASH
-
May 10, 2026, 15:13Deepak Lodha: PT and aPTT Mixing Study is a Key Tool in Coagulation Diagnosis
-
May 10, 2026, 15:12Marc Wittwer: Excellent Days at the 7th Coagulation Days in Zagreb
-
May 10, 2026, 15:12Tagreed Alkaltham: WB Donation vs Apheresis Donation – Understanding Donor Reactions and Why They Differ
-
May 10, 2026, 15:11Divyaswathi Citla Sridhar and Leonard Valentino Congratulate Roshni Kulkarni on Her Recognition as Advocate for Women and Girls with Bleeding Disorders
-
May 10, 2026, 15:09Haroun Gajraj: How Much of a Problem are Brown Marks after Sclerotherapy, Really?
-
May 10, 2026, 15:05Arun Chandran Nhattuvalappil: Simplifying Anticoagulation Decisions for Regional Anaesthesia with ASRA 2025 Guideline